Digitalising cancer pathways

The Covid-19 pandemic has driven digitalisation across healthcare services, including cancer care. Gordon Wishart, chief medical officer at Check4Cancer and visiting professor of cancer surgery at Anglia Ruskin University, looks at how lockdown spurred on the development of digital pathways and AI-powered diagnostics that could have a lasting impact on service delivery   One of…

You must be a HM Subscriber to view this content.

Subscribe Now »